SightfileU.S. market data from official filings

INTERCURE LTD COM NEW (INCR)

Name: INTERCURE LTD COM NEW (INCR) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001857030 · EDGAR filings · Updated 2026-07-27

INTERCURE LTD COM NEW (INCR) has reported institutional ownership of 1.1%, with 15 institutional managers holding positions valued at $617.9K per the latest 13F reporting period.

Institutional ownership

1.1%

Institutional managers

Reported 13F value

$617.9K

Filings this week (2)

2026-07-27 — 6-K/A filed
2026-07-22 — Foreign issuer report (6-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-06-22 — Foreign issuer report (6-K) filed
2026-06-15 — Foreign issuer report (6-K) filed
2026-05-01 — Foreign issuer report (6-K) filed
2026-04-30 — Annual report (20-F) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INTERCURE LTD COM NEW has 15 institutional holders and institutional ownership of 1.1%.

Related companies

GT BIOPHARMA INC (GTBP) · PHARMACYTE BIOTECH INC (PMCB) · INNOVATIVE EYEWEAR INC (LUCY) · Revelation Biosciences Inc (REVB) · CALCIMEDICA (CALC) · Astrotech Corporation (ASTC)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.